Multifunctional Block Copolymer Micelles for the Delivery of 111In to EGFR-Positive Breast Cancer Cells for Targeted Auger Electron Radiotherapy

被引:21
作者
Fonge, Humphrey
Lee, Helen
Reilly, Raymond M. [2 ,3 ]
Allen, Christine [1 ,4 ,5 ]
机构
[1] Univ Toronto, Dept Pharmaceut Sci, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada
[2] Univ Toronto, Dept Med Imaging, Toronto, ON M5S 3M2, Canada
[3] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada
[4] Univ Toronto, Dept Chem, Toronto, ON M5S 3M2, Canada
[5] Univ Hlth Network, Princess Margaret Hosp, Radiat Med Program, STTARR Innovat Ctr, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
Epidermal growth factor receptor; Auger electron radiotherapy; breast cancer; block copolymer micelle; In-111; EPIDERMAL-GROWTH-FACTOR; TUMOR VASCULAR-PERMEABILITY; FACTOR RECEPTOR; DRUG-DELIVERY; IN-VIVO; CELLULAR INTERNALIZATION; NANOPARTICLE FORMULATION; PHASE-I; THERAPY; DOXORUBICIN;
D O I
10.1021/mp900201v
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Block copolymer micelles (BCMs) can improve the payload delivery of therapeutic agents to tumors. Our aim was to construct hEGF-modified BCMs for the delivery of In-111 to tumor cells for Auger electron-emission radiotherapy of EGFR-positive breast cancer (BC). Multifunctional nanosized BCMs were prepared from MePEG(2500)-b-PCL1200 and In-111-DTPA-PEG(3000)-b-PCL1600 with or without hEGF-PEG(2900)-b-PCL1400 (In-111-hEGF-BCMs or In-111-BCMs). The resulting BCMs were analyzed by dynamic light scattering and transmission electron microscopy. Cellular uptake and nuclear importation were assessed in MDA-MB-468, MDA-MB-231 and MCF-7 BC cells with decreasing EGFR density. In vitro antiproliferative effects were evaluated using the WST-1 assay after 48 h with In-111-hEGF-BCMs, and the clonogenic assay was used to determine the survival fraction (SF) after a 21 h exposure. Results were compared with In-111-DTPA-hEGF, an established Auger electron-emitting radiotherapeutic that is currently in clinical development. Cell uptake and nuclear importation of In-111-hEGF-BCMs decreased in the following order: MDA-MB-468 > MDA-MB-231 > MCF-7. Cellular uptake of In-111-hEGF-BCMs was less than In-111-DTPA-hEGF (P < 0.05) but was 4-fold higher than for In-111-BCMs (P < 0.001). There was a significant growth inhibition of MDA-MB-468 cells by In-111-hEGF-BCMs (6-fold inhibition, P < 0.05) while the growth of MDA-MB-231 and MCF-7 were not significantly inhibited. The SF of MDA-MB-468 cells was decreased to 2.6% while that for MCF-7 cells was 132.7%. In-111-DTPA-hEGF reduced the SF of MDA-MB-468 cells to 0.4%. Nontargeted In-111-BCMs had minimal effect on the SF of BC cells. Therefore, the In-111-hEGF-BCMs were bound, internalized and transported to the nuclei of EGFR-positive BC cells, where the Auger electron emissions were lethal. The In-111-hEGF-BCMs are a promising delivery system for targeted radiotherapy of BC.
引用
收藏
页码:177 / 186
页数:10
相关论文
共 50 条
[1]   Amphiphilic block copolymers for drug delivery [J].
Adams, ML ;
Lavasanifar, A ;
Kwon, GS .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (07) :1343-1355
[2]   Cellular internalization of PCL20-b-PEO44 block copolymer micelles [J].
Allen, C ;
Yu, YS ;
Eisenberg, A ;
Maysinger, D .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1421 (01) :32-38
[3]   Nano-engineering block copolymer aggregates for drug delivery [J].
Allen, C ;
Maysinger, D ;
Eisenberg, A .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :3-27
[4]   Epidermal growth factor receptor inhibition modulates the nuclear localization and cytotoxicity of the auger electron-emitting radiopharmaceutical 111In-DTPA-human epidermal growth factor [J].
Bailey, Kristy E. ;
Costantini, Danny L. ;
Cai, Zhongli ;
Scollard, Deborah A. ;
Chen, Zhuo ;
Reilly, Raymond M. ;
Vallis, Katherine A. .
JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (09) :1562-1570
[5]   Multifunctional Micellar Nanomedicine for Cancer Therapy [J].
Blanco, Elvin ;
Kessinger, Chase W. ;
Sumer, Baran D. ;
Gao, Jinming .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2009, 234 (02) :123-131
[6]   Auger radiation targeted into DNA: a therapy perspective [J].
Buchegger, Franz ;
Perillo-Adamer, Florence ;
Dupertuis, Yves M. ;
Delaloye, Angelika Bischof .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (11) :1352-1363
[7]   Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF [J].
Cai, Zhongli ;
Chen, Zhuo ;
Bailey, Kristy E. ;
Scollard, Deborah A. ;
Reilly, Raymond M. ;
Vallis, Katherine A. .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (08) :1353-1361
[8]  
Chen P, 2003, J NUCL MED, V44, P1469
[9]   Comparative antiproliferative effects of 111In-DTPA-hEGF, chemotherapeutic agents and γ-radiation on EGFR-positive breast cancer cells [J].
Chen, P ;
Mrkobrada, M ;
Vallis, KA ;
Cameron, R ;
Sandhu, J ;
Hendler, A ;
Reilly, RM .
NUCLEAR MEDICINE AND BIOLOGY, 2002, 29 (06) :693-699
[10]   Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP 1049C) in patients with advanced cancer [J].
Danson, S ;
Ferry, D ;
Alakhov, V ;
Margison, J ;
Kerr, D ;
Jowle, D ;
Brampton, M ;
Halbert, G ;
Ranson, M .
BRITISH JOURNAL OF CANCER, 2004, 90 (11) :2085-2091